cilostazol has been researched along with Atheroma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol treatment for 6 months significantly attenuated the progression of carotid plaque compared with aspirin in patients with T2D (NCT03248401)." | 2.94 | Effect of cilostazol on carotid plaque volume measured by three-dimensional ultrasonography in patients with type 2 diabetes: The FANCY study. ( Chun, EJ; Lee, DH; Lim, S; Moon, JH; Yun, HM, 2020) |
| "Cilostazol is an antiplatelet agent that can induce the regression of atherosclerosis." | 1.40 | Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy. ( Narumi, S; Ohba, H; Oura, K; Sasaki, M; Terayama, Y; Uwano, I; Yamaguchi Oura, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, DH | 1 |
| Chun, EJ | 1 |
| Moon, JH | 1 |
| Yun, HM | 1 |
| Lim, S | 1 |
| Park, KY | 1 |
| Heo, TH | 1 |
| Kim, SM | 1 |
| Cho, KI | 1 |
| Yamamoto, Y | 1 |
| Yamaguchi Oura, M | 1 |
| Sasaki, M | 2 |
| Ohba, H | 2 |
| Narumi, S | 2 |
| Oura, K | 1 |
| Uwano, I | 1 |
| Terayama, Y | 2 |
| Takeda, M | 1 |
| Yamashita, T | 1 |
| Shinohara, M | 1 |
| Sasaki, N | 1 |
| Tawa, H | 1 |
| Nakajima, K | 1 |
| Momose, A | 1 |
| Hirata, K | 1 |
| Yamaguchi, M | 1 |
| Mori, K | 1 |
| Katsura, N | 1 |
| Ohura, K | 1 |
| Kudo, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Cilostazol, a Phosphodiesterase 3 Inhibitor, on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes[NCT03248401] | Phase 4 | 50 participants (Actual) | Interventional | 2016-09-26 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cilostazol and Atheroma
| Article | Year |
|---|---|
[Concept, pathophysiology and treatment for branch atheromatous disease].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Clopidogrel; Contraindications; Drug Therapy, | 2014 |
1 trial available for cilostazol and Atheroma
| Article | Year |
|---|---|
Effect of cilostazol on carotid plaque volume measured by three-dimensional ultrasonography in patients with type 2 diabetes: The FANCY study.
Topics: Carotid Intima-Media Thickness; Cilostazol; Diabetes Mellitus, Type 2; Female; Humans; Male; Plaque, | 2020 |
5 other studies available for cilostazol and Atheroma
| Article | Year |
|---|---|
Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cell Adhesion Molecules; Cholesterol, Dietary; Cil | 2018 |
Impact of cilostazol on the progression of carotid atherosclerosis in patients with retinal vascular occlusion.
Topics: Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cilostazol; | 2013 |
Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy.
Topics: Aged; Carotid Artery Diseases; Cilostazol; Female; Fibrosis; Humans; Imaging, Three-Dimensional; Int | 2014 |
Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Brachiocephalic Trunk; Cell Adhesio | 2012 |
Quantitative assessment of changes in carotid plaques during cilostazol administration using three-dimensional ultrasonography and non-gated magnetic resonance plaque imaging.
Topics: Aged; Carotid Stenosis; Cilostazol; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance I | 2012 |